|
|
|
|
|||||
|
|
|
New: Introducing “Why Is It Moving?” - lightning-fast, AI-driven explanations of stock moves
GAITHERSBURG, Md., Sept. 3, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the following upcoming investor conference:
Cantor Global Healthcare Conference: | |
Fireside Chat | |
Date: | Thursday, September 4, 2025 |
Time: | 10:20 a.m. ET |
Location: | New York, NY |
A webcast of the fireside chat will be available on the Events & Presentations page of the Company's website at ir.novavax.com. A replay of the webcast will be available for 30 days.
About Novavax
Novavax, Inc. (Nasdaq: NVAX) tackles some of the world's most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including protein-based nanoparticles and its Matrix-M adjuvant. The Company's growth strategy seeks to optimize its existing partnerships and expand access to its proven technology platform via R&D innovation, organic portfolio expansion in infectious disease and beyond, and forging new partnerships and collaborations with other companies. Please visit novavax.com and LinkedIn for more information.
Contacts:
Investors
Luis Sanay, CFA
240-268-2022
[email protected]
Media
Giovanna Chandler
844-264-8571
[email protected]
SOURCE Novavax, Inc.
| Oct-14 | |
| Oct-14 | |
| Oct-08 | |
| Oct-07 | |
| Oct-06 | |
| Sep-30 | |
| Sep-30 | |
| Sep-26 | |
| Sep-25 | |
| Sep-23 | |
| Sep-19 | |
| Sep-18 |
The Battle Over Covid Vaccines Hits A Fever Pitch As RFK-Picked Panel Makes Its Debut
NVAX
Investor's Business Daily
|
| Sep-17 | |
| Sep-17 | |
| Sep-15 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
